Komori
StemCell Institute (7096) · InitiativeFirst stated

Grant of stock acquisition rights to officers and employees

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 703 companies write about · 0 as a headwind · 787 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 789 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「(First Series of Stock Acquisition Rights) Date of issue and allotment of stock acquisition rights: 22 July 2026　Directors of the company: 1　Common shares: 51,400 (Note)　Exercise period for stock acquisition rights: 1 August 2030 to 31 July 2034 (Second Series of Stock Acquisition Rights) Directors of the company: 1　Executive officers of the company: 4　Common shares: 105,000　Exercise period for stock acquisition rights: 1 August 2030 to 31 July 2032 (Third Series of Stock Acquisition Rights) Date of issue and allotment of stock acquisition rights: 12 August 2026　Employees of a subsidiary of the company: 2　Common shares: 20,000　Exercise period for stock acquisition rights: 1 August 2030 to 31 July 2032」

    In July and August 2026, the company issued stock acquisition rights for a total of 176,400 shares to directors, executive officers and employees of a subsidiary. The exercise period begins in 2030.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Grant of stock acquisition rights to officers and employees | StemCell Institute (7096) | Komori